Investor Centre
Investor Highlights
Pharmaxis Announces First Sales of Aridol® in USA
Pharmaceutical research company Pharmaxis (ASX: PXS) today announced the first sales of its asthma diagnostic Aridol® (mannitol bronchial challenge test) in the United States following the relaunch of the product.
Read full media release - pdfProactive Investors Interview with Gary Phillips
Proactive Investors Interview with Pharmaxis Ltd CEO Gary Phillips on 23 November 2018.
Chairman's Address to 2018 Annual General Meeting
Chairman's Address by Malcolm McComas to the 2018 Annual General Meeting
Read full ASX announcement – pdfCEO Presentation to 2018 AGM
Presentation by the Pharmaxis CEO and CFO to the 2018 AGM
View presentation – pdfInvestor Research Briefing Presentations
Presentations from the Investor Research Briefing held on 20 November 2018.
View presentation – pdf